FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000586809> ?p ?o ?g. }

• W2000586809 abstract "Topotecan (TPT) is a therapeutic option for women with platinum-resistant or -refractory ovarian cancer. However, the dose-limiting toxicity of TPT is myelosuppression. This led us to seek a combination treatment to augment TPT anti-cancer activity in a cancer-targeted manner. Ovarian serous cancers, a major subtype, show dysregulated DNA repair pathway and often display a high level of CHEK1 (CHK1), a cell cycle regulator and DNA damage sensor. CHEK1 inhibitors are a novel approach to treatment, and have been used as single agents or in combination chemotherapy in many cancers. We evaluated the cellular effects of TPT in a panel of high grade serous (HGS) and non-HGS ovarian cancer cells. We then determined IC50s of TPT in the absence and presence of CHEK1 inhibitor, PF477736. Synergism between TPT and PF477736 was calculated based on cellular viability assays. Cytotoxic effect of the combined treatment was compared with apoptotic activities by Caspase3/7 activity assay and Western blotting of cleaved-PARP1 and γH2AX. Non-HGS ovarian cancer cells were generally more sensitive to TPT treatment compared to HGS ovarian cancer cells. When combined with CHEK1 inhibitor, TPT potently and synergistically inhibited the proliferation of HGS ovarian cancer cells. This dramatic synergism in cellular toxicity was consistent with increases in markers of apoptosis. Our findings suggest that the addition of CHEK1 inhibitor increases the response of ovarian cancer cells to TPT. Furthermore, reduced dosages of both drugs achieved maximal cytotoxic effects by combining TPT with CHEK1 inhibitor. This strategy would potentially minimize side effects of the drugs for extended clinical benefit." @default.
• W2000586809 created "2016-06-24" @default.
• W2000586809 creator A5001707572 @default.
• W2000586809 creator A5028772864 @default.
• W2000586809 creator A5071625751 @default.
• W2000586809 date "2015-03-28" @default.
• W2000586809 modified "2023-09-30" @default.
• W2000586809 title "Topotecan synergizes with CHEK1 (CHK1) inhibitor to induce apoptosis in ovarian cancer cells" @default.
• W2000586809 cites W1515441890 @default.
• W2000586809 cites W1970336739 @default.
• W2000586809 cites W1987604182 @default.
• W2000586809 cites W1997338647 @default.
• W2000586809 cites W1999022874 @default.
• W2000586809 cites W2019502079 @default.
• W2000586809 cites W2043398720 @default.
• W2000586809 cites W2043703023 @default.
• W2000586809 cites W2063393084 @default.
• W2000586809 cites W2086409356 @default.
• W2000586809 cites W2095986441 @default.
• W2000586809 cites W2105427724 @default.
• W2000586809 cites W2105578128 @default.
• W2000586809 cites W2105663975 @default.
• W2000586809 cites W2110994269 @default.
• W2000586809 cites W2117639046 @default.
• W2000586809 cites W2118106551 @default.
• W2000586809 cites W2123696077 @default.
• W2000586809 cites W2142215602 @default.
• W2000586809 cites W2146106055 @default.
• W2000586809 cites W2148577079 @default.
• W2000586809 cites W2153262774 @default.
• W2000586809 cites W2155205362 @default.
• W2000586809 cites W2170928115 @default.
• W2000586809 doi "https://doi.org/10.1186/s12885-015-1231-z" @default.
• W2000586809 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4379550" @default.
• W2000586809 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25884494" @default.
• W2000586809 hasPublicationYear "2015" @default.
• W2000586809 type Work @default.
• W2000586809 sameAs 2000586809 @default.
• W2000586809 citedByCount "40" @default.
• W2000586809 countsByYear W20005868092015 @default.
• W2000586809 countsByYear W20005868092016 @default.
• W2000586809 countsByYear W20005868092017 @default.
• W2000586809 countsByYear W20005868092018 @default.
• W2000586809 countsByYear W20005868092019 @default.
• W2000586809 countsByYear W20005868092020 @default.
• W2000586809 countsByYear W20005868092021 @default.
• W2000586809 countsByYear W20005868092022 @default.
• W2000586809 countsByYear W20005868092023 @default.
• W2000586809 crossrefType "journal-article" @default.
• W2000586809 hasAuthorship W2000586809A5001707572 @default.
• W2000586809 hasAuthorship W2000586809A5028772864 @default.
• W2000586809 hasAuthorship W2000586809A5071625751 @default.
• W2000586809 hasBestOaLocation W20005868091 @default.
• W2000586809 hasConcept C104317684 @default.
• W2000586809 hasConcept C105696609 @default.
• W2000586809 hasConcept C121608353 @default.
• W2000586809 hasConcept C126322002 @default.
• W2000586809 hasConcept C143425029 @default.
• W2000586809 hasConcept C154317977 @default.
• W2000586809 hasConcept C182979987 @default.
• W2000586809 hasConcept C185592680 @default.
• W2000586809 hasConcept C202751555 @default.
• W2000586809 hasConcept C2776694085 @default.
• W2000586809 hasConcept C2778239845 @default.
• W2000586809 hasConcept C2779138821 @default.
• W2000586809 hasConcept C2779962180 @default.
• W2000586809 hasConcept C2780427987 @default.
• W2000586809 hasConcept C2781209748 @default.
• W2000586809 hasConcept C2781451048 @default.
• W2000586809 hasConcept C29537977 @default.
• W2000586809 hasConcept C50001416 @default.
• W2000586809 hasConcept C502942594 @default.
• W2000586809 hasConcept C552990157 @default.
• W2000586809 hasConcept C55493867 @default.
• W2000586809 hasConcept C71924100 @default.
• W2000586809 hasConcept C82381507 @default.
• W2000586809 hasConcept C96232424 @default.
• W2000586809 hasConcept C98274493 @default.
• W2000586809 hasConceptScore W2000586809C104317684 @default.
• W2000586809 hasConceptScore W2000586809C105696609 @default.
• W2000586809 hasConceptScore W2000586809C121608353 @default.
• W2000586809 hasConceptScore W2000586809C126322002 @default.
• W2000586809 hasConceptScore W2000586809C143425029 @default.
• W2000586809 hasConceptScore W2000586809C154317977 @default.
• W2000586809 hasConceptScore W2000586809C182979987 @default.
• W2000586809 hasConceptScore W2000586809C185592680 @default.
• W2000586809 hasConceptScore W2000586809C202751555 @default.
• W2000586809 hasConceptScore W2000586809C2776694085 @default.
• W2000586809 hasConceptScore W2000586809C2778239845 @default.
• W2000586809 hasConceptScore W2000586809C2779138821 @default.
• W2000586809 hasConceptScore W2000586809C2779962180 @default.
• W2000586809 hasConceptScore W2000586809C2780427987 @default.
• W2000586809 hasConceptScore W2000586809C2781209748 @default.
• W2000586809 hasConceptScore W2000586809C2781451048 @default.
• W2000586809 hasConceptScore W2000586809C29537977 @default.
• W2000586809 hasConceptScore W2000586809C50001416 @default.
• W2000586809 hasConceptScore W2000586809C502942594 @default.
• W2000586809 hasConceptScore W2000586809C552990157 @default.
• W2000586809 hasConceptScore W2000586809C55493867 @default.
• W2000586809 hasConceptScore W2000586809C71924100 @default.

• next